Business Update & Preliminary 1H26 Results
Filed with ASX · · 4 pages · English
Watch Cogstate's latest callCogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cogstate (ASX:CGS) Q4 2026 Earnings CallCogstate Ltd (ASX: CGS) today announces unaudited sales and revenue results for the half year ended 31 December 2025 (1H26). The period delivered strong growth in clinical trial sales contracts, driven by a significantly higher contribution from non-Alzheimer’s indications and a broader sponsor base, supporting a more diversified, resilient, and repeatable revenue and earnings profile. Highlights
Earlier from Cogstate
- Cogstate Business Update
- S&P DJI Announces December 2025 Quarterly Rebalance
- FY25 Results Investor Briefing
- FY25 Financial Results and Operational Update
- Appendix 4E
Later from Cogstate
- 1H25 Investor Presentation Materials
- App 4D and Financial Statements Half-Year Ended 31 Dec 2025
- Cogstate 1H26 Financial Results
- Cogstate 3Q26 Business Update
- Cogstate 4Q26 and FY26 Business Update
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate